Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that complex therapy including biomimetic peptides was effective in treating alopecia compared to a similar treatment without the peptides.

This study developed a novel smart deoxyribozyme-based fluorescent sensor that efficiently detects androgen receptor mRNA with high selectivity and can be adapted to target various nucleic acid sequences.

This study found that combining topical capislow with laser hair removal significantly enhanced hair reduction compared to laser alone, although the beneficial effects lasted only while capislow was applied.

This article describes a modified follicular unit extraction technique using a reverse rake scalp elevator, which may reduce follicular transection rates in hair transplantation from the lower occipital donor region.

This letter discusses a case of Hepatitis C-related vitiligo in a patient with Ivemark syndrome and presents no new clinical results.

This article discusses the characteristics of human hair, its damaging processes, and the potential repair effects of immuno-cosmeceuticals, but it reports no new clinical results.

The authors clarified data overlap and corrected a figure error, apologizing for any confusion.

In this report, researchers describe a 13-month-old with neurodevelopmental disorder NEDESBA, confirming a TRAPPC4 gene mutation as the cause after excluding biotinidase deficiency, highlighting the importance of molecular testing for accurate diagnosis in overlapping metabolic and genetic conditions.

In this study, researchers observed that men with androgenic alopecia in a Pakistani population had significantly lower hair density than those without hair loss, particularly at the frontal and parietal scalp regions.

This study found that patients with alopecia areata had significantly lower serum 25-Hydroxy vitamin D levels compared to healthy controls, and observed a significant inverse relationship between vitamin D levels and disease severity.

This case-control study in Missan Province, Iraq, found that married women with PCOS had higher rates of obesity and menstrual irregularities, along with elevated testosterone, LH, and insulin levels, compared to healthy controls, highlighting significant hormonal and metabolic complications.

This study found that both oral afoxolaner (NexGard®) and topical Frontline Combo® achieved 100% efficacy in eradicating Heterodoxus spiniger infestations within 30 days in dogs, with significant reductions in associated symptoms like hair loss and pruritus.

This study found that platelet-rich plasma therapy led to significantly increased hair growth and density compared to placebo in patients with androgenic alopecia over six months.

This study found that QR678 Neo® significantly enhanced hair regrowth, density, and shaft diameter in males with advanced androgenetic alopecia undergoing hair transplant surgery, compared to a conventional method, making it a promising adjunct treatment option.

This study found that men with androgenetic alopecia had significantly higher rates of dry eye symptoms and meibomian gland dysfunction compared to healthy controls, suggesting a potential link between the condition and these ocular issues.

In this study, oral minoxidil treatment significantly increased serum VEGF levels and improved hair growth measures compared to a control group, suggesting its potential as an effective approach for promoting hair regrowth in androgenetic alopecia.

This study found that among adult balding men in Rawalpindi and Islamabad, those seeking hair transplants exhibited higher levels of perfectionism and body dysmorphic disorder symptoms compared to those not seeking treatment.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

This study found that using platelet-rich plasma alongside minoxidil and finasteride/spironolactone during hair transplant surgery for androgenetic alopecia improved follicle survival, hair growth rates, and hair strength.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

In this study of 60 patients aged 1 to 60 with clinically diagnosed scalp diseases, researchers identified age, sex, educational level, occupation, socio-economic condition, family history, and behavior as factors associated with the prevalence of these diseases.

This study identified 11 previously unreported ABCA12 variants associated with varying severities of autosomal recessive congenital ichthyoses and expanded the phenotype spectrum of ichthyosis linked to these variants.

This study found that TCF7L2 gene polymorphism is linked to alopecia areata, but no significant difference in treatment outcomes was observed between PRP and conventional therapy among different genotypes.

This study found that Baricitinib significantly reduced hair loss and immune response in a mouse model of alopecia areata.

This case report described a woman in her 40s with ulcerative scalp sarcoidosis presenting in atypical skin locations, diagnosed with systemic sarcoidosis following comprehensive examination and histological analysis, and experiencing improvement with prednisone and hydroxychloroquine treatment.

This study found that co-administering sasam-Kyeongokgo with gefitinib enhanced gefitinib's anti-tumor activity and exhibited favorable anti-cachexia effects in mice with non-small-cell lung cancer.

This study found that combining FUE transplantation with rb-bFGF gel and minoxidil tincture significantly improved hair survival, reduced hair loss, and increased patient satisfaction in cicatricial alopecia treatment, compared to FUE alone, with fewer adverse effects reported within 12 months post-surgery.

This study found that androgenic alopecia may serve as an early marker for benign prostatic hyperplasia.

This study reports that while DCP had similar treatment efficacy in propylene glycol and isopropanol for alopecia areata, the formulation in isopropanol was better tolerated.

This study found that administering botulinum toxin A via Flex-PADs to mouse footpads inhibited sweating similarly to traditional injections, suggesting a promising patient-friendly delivery method for hyperhidrosis treatment.